Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
Liaoning Cancer Hospital & Institute
Liaoning Cancer Hospital & Institute
Henan Cancer Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The First Affiliated Hospital with Nanjing Medical University
Shengjing Hospital
Shengjing Hospital
Shandong Cancer Hospital and Institute
Sun Yat-sen University
Zhejiang Cancer Hospital
Rigshospitalet, Denmark
Henan Cancer Hospital
Clinica Universidad de Navarra, Universidad de Navarra
Xijing Hospital
M.D. Anderson Cancer Center
Jinling Hospital, China
Karolinska University Hospital
Peking University First Hospital
Hospital Affiliated to Military Medical Science, Beijing
ChineseAMS
AHS Cancer Control Alberta
Guangxi Medical University
Anhui Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fudan University
Auxilio Mutuo Cancer Center
ChineseAMS
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Department of Veterans Affairs, New Jersey